TRENTON, N.J. - Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration (FDA) in recent months has rejected a slew of experimental drugs or delayed their approval and required more data. Besides keeping drugs some patients might desperately need off the market, the rejections have battered drug company stock prices and are
Bill will allow some to file lawsuits
Some Oregonians could sue Merck, the maker of the now-withdrawn pain medication Vioxx, under a bill that is headed for the desk of Gov. Ted Kulongoski.
Merck Urges Judge to Dismiss Federal Vioxx Securities Lawsuits
March 26 (Bloomberg) -- A Merck & Co. lawyer urged a federal judge to dismiss securities lawsuits claiming the company defrauded investors before withdrawing its Vioxx painkiller from the market in September 2004. Click here for more infoStatistics Expert Testifies in Vioxx Case
Jurors on a product liability case over the painkiller Vioxx heard Thursday from a medical statistics expert, a day after an executive for manufacturer Merck & Co. said the company tried to speed development of the drug.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved